SPRY fund manager activity
ARS Pharmaceuticals, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q3 2024 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ron Baron - Baron Capital | No change | 1,268,532 | $14,778,398 | 0.04% | Feb 17, 2026 |
| Daniel Loeb - Third Point | New | 556,237 | $6,480,161 | 0.09% | Feb 17, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ron Baron - Baron Capital | Added | 1,268,532 | $12,748,747 | 0.03% | Nov 14, 2025 |
| Joel Greenblatt - Gotham Asset Management | Sold out | — | — | 0.00% | Nov 14, 2025 |